Summary by Moomoo AI
MEDLIVE Technology announced its annual performance for 2024, achieving revenue of 0.5585 billion yuan RMB, a year-on-year increase of 35.5%; net profit of 0.3303 billion yuan RMB, a year-on-year increase of 31.2%. The gross margin remained at 58.6%, with cash and cash equivalents reaching 3.8447 billion yuan RMB, and debt investments amounting to 0.6395 billion yuan RMB.As China's leading online professional physician platform, the company's main businesses include three major sectors: precision marketing and enterprise solutions, medical knowledge solutions, and intelligent patient management solutions. The platform already has over 7 million registered physician users, covering 88% of practicing physicians nationwide.During the year, the company issued 5.9135 million shares through a stock options plan, with an exercise price of 0.38 yuan RMB per share, totaling 2.25 million yuan RMB. The company maintains a zero debt ratio, has no external borrowings, and actively manages Forex risk exposure, demonstrating robust risk management capabilities.
